IMMUNOPRECISE ANTIBODIES LTD (IPA)

CA45257F2008 - Common Stock

1.88  +0.02 (+1.08%)

IMMUNOPRECISE ANTIBODIES LTD

NASDAQ:IPA (9/28/2023, 7:00:03 PM)

1.88

+0.02 (+1.08%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)09-14 2023-09-14/bmo
Earnings (Next)12-13 2023-12-13/bmo
Ins OwnersN/A
Inst Owners5.74%
Market Cap46.88M
Shares24.94M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts80
IPO01-30 1987-01-30
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

IPA Daily chart

Company Profile

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The company is headquartered in Victoria, British Columbia and currently employs 102 full-time employees. The firm offers species-agnostic advancements, such as the B cell Select single-cell interrogation technology, DeepDisplay custom phage libraries, as well as the Abthena bispecific program- platforms. The company leverages systems biology, multi-omics modelling and complex artificial intelligence systems to support its technologies in bio platform-based antibody discovery. The company offers a selection of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma licensing for research purposes. Its services include specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners. The firm offers support to its partners, including rapid multi-omic analysis, customized project design, target identification and preparation, an on-site vivarium, and others.

Company Info

IMMUNOPRECISE ANTIBODIES LTD

3204-4464 Markham St

Victoria BRITISH COLUMBIA

P: 12504830308.0

Employees: 102

Website: https://www.ipatherapeutics.com/

IPA News

News Image10 days ago - Seeking AlphaImmunoPrecise Antibodies CFO resigns, interim CFO appointed (NASDAQ:IPA)

ImmunoPrecise Antibodies (IPA) said on Tuesday that Brad McConn has resigned as CFO, effective Sep. 29.

News Image10 days ago - ImmunoPrecise Antibodies Ltd.ImmunoPrecise Antibodies Announces CFO Transition
News Image15 days ago - ImmunoPrecise Antibodies Ltd.IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
News Image21 days ago - ImmunoPrecise Antibodies Ltd.IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023
News Image24 days ago - ImmunoPrecise Antibodies Ltd.IPA Announces Board Refreshment
News Image2 months ago - ImmunoPrecise Antibodies Ltd.IPA Responds to 13D Filing

IPA Twits

Here you can normally see the latest stock twits on IPA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example